Category Archives: Healthcare

Development of US and Chinese Retail Giants in the Healthcare Sector | Aarkstore

Retail Healthcare Sector

Aarkstore Market Research published the new epoch of Market Research Report “Development Of US And Chinese Retail Giants In The Healthcare Sector

Since the end of 2017, several leading international retailers have conducted acquisitions and initiated investments in attempts to tap into the growing healthcare industry. The healthcare industry generally comprises of medical, pharmaceutical, and insurance components. This report provides an overview of acquisitions and investment plans of four retail giants: CVS Health, Walgreens, Amazon, and Alibaba in the healthcare space, outlines their existing healthcare landscape and advantages, and analyzes their strategies to drive their business in this arena.

  1. Development of retail brands in Healthcare sector
    1.1 Primary Healthcare Services Only
    1.2 Traditional Companies vs. Startups
    2. RetaiL brands Existing Healthcare Landscape
    3. Deployment strategies
    3.1 CVS Aims for Business Diversification by Integrating Medical, Pharmaceutical, and Insurance Services
    3.2 Walgreens Adds Telemedicine Services to Enhance Existing Medical Care Services
    3.3 Amazon Enters Medical Care Service for the First Time to Capture the Seniors Market
    3.4 Alibaba Aims to Deepen Presence in O2O Prescription Drug Services
    MIC Perspective
    Prescription Drugs and Medical Insurance are the Areas of Focus for Retail Giants
    Creating Service Differentiation is Key to Success
    Appendix
    Glossary of Terms
    List of Companies
    List of Tables
    Table 1 Overview of M&As of International Retail Giants
    Table 2 Self-operated Healthcare Service of Amazon and Walgreens
    Table 3 Retail Brands Deployment in the Healthcare Sector
    List of Figures
    Figure 1 Retail Giants Strategies for Healthcare Market Expansion

    List Of Tables

    Development of retail brands in the healthcare sector, touching on their main service types and the comparison between traditional companies and startups in this arena
    Retail brands existing healthcare landscape and includes their M&A activities in recent years
    Deployment strategies of leading retail brands such as CVS, Walgreen, Amazon, and Alibaba

    List Of Figures

    Figure 1 Retail Giants Strategies for Healthcare Market Expansion

For more inquiry contact our sales team at contact@aarkstore.com

Related Reports:

Contact Details:

Aarkstore Enterprise
Phone: +91 – 22 2756 4963
24/7 Online Support: +91 9987295242
Email: enquiry@aarkstore.com
Our website: https://www.aarkstore.com
Our blog: https://www.aarkstore.com/blog

Advertisements

Global Blood Plasma Market Opportunities and Forecast (2013-2023) | Aarkstore

Blood Plasma

Aarkstore Enterprise announced latest Market Research Report Titled “Global Blood Plasma Market Opportunities and Forecast (2013-2023)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis Global Blood Plasma Market. The report analyses the Blood Plasma Market By Type (Immunoglobulins- IV+SC, Albumin, Factor VIII- Plasma Derived, and Others), By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S, Canada, Germany, France, Italy, China, Japan, India, Australia, and South-East Asia). The report on Blood Plasma assesses the market for the actual period of 2013-2017 and the forecast period of 2018-2023.

According to the research report “Global Blood Plasma Market – Analysis By Type (Immunoglobulins – IV+SC, Albumin, Factor VIII – Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)”, the global blood plasma market is projected to display a robust growth represented by a CAGR of 10.18% during 2018 – 2023.

The Blood Plasma market witness a substantial growth at a noteworthy rate over the past few years and anticipated to grow on the back of its increasing usage in plasma-derived medical products. In addition, rise in awareness towards plasma donation, rise of China blood plasma industry, introduction of new and specialized products, rising geriatric population, rapid increase of the healthcare expenditure on the diseases such as immunodeficiency, neurological disorders, clotting disabilities etc. anticipated to boost the market growth in future. Amongst the regions, North America accounts for the largest regional share in the global blood plasma market. Key factor driving the robust growth rate in North America region is collection of source plasma in large volume for the fractionation process.

The report titled “Global Blood Plasma Market – Analysis By Type (Immunoglobulins – IV+SC, Albumin, Factor VIII – Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)” has covered and analysed the potential of Global Blood Plasma Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global blood ingredients market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Blood Plasma Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Blood Plasma Market – Size, Growth, Forecast
• Analysis By Type- Size, Volume, Growth, Forecast
o Immunoglobulin (IV+SC)
o Albumin
o Factor VIII (Plasma Derived)

Regional Markets – North America, Europe, Asia Pacific, and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Blood Plasma Market – Size, Growth, Forecast
• Analysis By Type
o Immunoglobulin (IV+SC)
o Albumin
o Factor VIII (Plasma Derived)

Country Analysis – U.S., Canada, Germany, France, Italy, China, Japan, India, Australia, and South-East Asia. (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Blood Plasma Market – Size, Growth, Forecast
• Analysis By Type
o Immunoglobulin (IV+SC)
o Albumin
o Factor VIII (Plasma Derived)

Other Report Highlights
• Market Dynamics – Drivers and Restraints
• Market Trends
• Porter Five Forces Analysis
• Company Analysis – CSL Limited, Baxter International, Grifols S.A, Octa Pharma, Emergent Bio-solutions, Antaris Pharma, AMAG Pharma, Biota Pharma, Bio delivery Science International, Biotest A.G.

For more inquiry contact our sales team at contact@aarkstore.com

Related Reports:

Contact Details:

Aarkstore Enterprise
Phone: +91 – 22 2756 4963
24/7 Online Support: +91 9987295242
Email: enquiry@aarkstore.com
Our website: https://www.aarkstore.com
Our blog: https://www.aarkstore.com/blog

 

Pharmaceuticals and Healthcare – Autoimmune Drugs Markets in China

Autoimmune Drugs

Chinas demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines Chinas economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2007, 2012 and 2017) and long-term forecasts through 2022 and 2027 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

For more inquiry contact our sales team at contact@aarkstore.com

Related Reports:

Autoimmune Drugs Companies in China

Global Autoimmune Disease Diagnosis Market Professional Survey Report 2018

Global Autoimmune Partnering 2012-2018: Deal trends, players and financials

Global Autoimmune Disorders Treatment Market Research Report 2016

Autoimmune Technologies, LLC Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

 

Contact Details:

Aarkstore Enterprise
Phone: +91 – 22 2756 4963
24/7 Online Support: +91 9987295242
Email: enquiry@aarkstore.com
Our website: http://www.aarkstore.com
Our blog: http://www.aarkstore.com/blog

 

Global Immunology Market Size and Revenue Forecasts

ImmunologySummary
Immune-mediated inflammatory diseases are a very common set of chronic disorders that affect 5–7% of western populations. Although they are often disparate in terms of their symptoms and key patient demographics, they are pathophysiologically linked, being characterized by dysregulation of immune pathways and an inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a highly genericized class of systemic small-molecule-based agents, are used in the first-line treatment of these diseases. These are supplemented in many cases by shorter-term glucocorticoid therapy, another class of highly genericized systemic agents.

However, as these therapies often fail to elicit an adequate long-term response, a large second-line therapy segment has emerged in these markets, beginning with the approval of Remicade (infliximab) and Enbrel (etanercept) in 1998. This segment consists largely of premium systemic monoclonal Antibodies (mAbs), which are highly commercially successful due to their widespread usage and high cost. Although the patents for many of these mAbs either have already expired or are due to expire during the forecast period, the market is expected to experience continued growth.

Request for Sample Market Report @http://www.aarkstore.com/sample/184047

Scope
Although the patents for many of these mAbs either have already expired or are due to expire during the forecast period, the market is expected to experience continued growth, from $61.5 billion in 2015 to $74.2 billion in 2022, at a compound annual growth rate of 2.71%.
– What factors are driving the market growth?
– How can the factors limiting growth be overcome?
There is a very large pharmaceutical pipeline for immunology, consisting of 1,838 products in active development. However, the commercial performance of the products in the late-stage pipeline is expected to be moderate.
– What gaps in the market are being addressed by the most promising of these late-stage pipeline products?
– How does the composition of the pipeline compare with that of the existing market?
Several key commercially successful products, including Humira (adalimumab) and Remicade, are due to lose patent protection in the forecast period.
– How will this affect their revenues in this period?
– How are their manufacturers, AbbVie and Johnson & Johnson, responding to this?

Reasons to buy market research
This report will allow you to –
– Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis
– Visualize the composition of the immunology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players
– Analyze the immunology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications
– Understand the growth in patient epidemiology and market revenues for the immunology market globally and across the key players and product types
– Stratify the market in terms of the split between generic and premium products and assess the role of these product types in the treatment of the various immunological disorders

Related Market Research Reports :

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Hepatitis A Virus Cellular Receptor 2-Pipeline Review, H1 2017

Hepatitis A Virus Cellular Receptor 2Summary
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) – Hepatitis A virus cellular receptor 2 (HAVCR2) is a protein encoded by the HAVCR2 gene. It inhibits T-helper type 1 lymphocyte (Th1)-mediated auto- and alloimmune responses and promotes immunological tolerance.

Request for Sample Market Report @http://www.aarkstore.com/sample/521276

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) pipeline Target constitutes close to 15 molecules. Out of which approximately 15 molecules are developed by Companies.

The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Scope
– The report provides a snapshot of the global therapeutic landscape for Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2)
– The report reviews Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved in Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) targeted therapeutics and enlists all their major and minor projects
– The report assesses Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects

Reasons to buy market report
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand the targeted therapy areas and indications for Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2)
– Identify the use of drugs for target identification and drug repurposing
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

Related Market Research Reports :

Asia-Pacific Ebola Virus Vaccine Market Report 2017

Global Zika Virus Market Research Report 2017

Autoimmune Hepatitis Global Clinical Trials Review, H1, 2017

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Global Chlamydia Tests – Medical Devices Pipeline Assessment, 2017

Chlamydia Tests - Medical DevicesSummary
Chlamydia Tests – Medical Devices Pipeline Assessment, 2017” provides an overview of Chlamydia Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Chlamydia Tests pipeline products.

Request for Sample Market Report @ http://www.aarkstore.com/sample/500109

Scope

– Extensive coverage of the Chlamydia Tests under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Chlamydia Tests and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy market report

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Chlamydia Tests under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Related Market Research Reports:

Chlamydia Infections – Pipeline Review, H1 2017

Hepatitis Viruses Diagnostic Tests – Medical Devices Pipeline Assessment, 2016

Melanoma Diagnostic Tests – Medical Devices Pipeline Assessment, 2016

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Respiratory Syncytial Virus (RSV) Infections – Therapeutics Development

Respiratory Syncytial VirusSummary

latest Pharmaceutical and Healthcare disease pipeline guide Respiratory Syncytial Virus (RSV) Infections – Pipeline Review, H1 2017, provides an overview of the Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) pipeline landscape.

Respiratory syncytial virus (RSV) infection is a respiratory disease. It infects the lungs and breathing passages. RSV commonly causes bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children less than one year of age. The symptoms of RSV infection include cough, stuffy or runny nose, mild sore throat, earache and fever. Treatment includes proper medication and hygiene practice.

Request for Sample Market Report @http://www.aarkstore.com/sample/500063

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Respiratory Syncytial Virus (RSV) Infections (Infectious Disease).
– The pipeline guide reviews pipeline therapeutics for Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.

Reasons to buy Market Report

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Respiratory Syncytial Virus (RSV) Infections (Infectious Disease).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Respiratory Syncytial Virus (RSV) Infections – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Respiratory Syncytial Virus (RSV) Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Related Market Research Reports:

Global Respiratory Equipment Sales Market Report 2017

Global Respiratory Devices Sales Market Report 2017

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

%d bloggers like this: